Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
Study Type: Interventional
Study Design:
Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking:
Open Label Primary Purpose: Treatment purpose: This single arm clinical trial is studying
efficacy and tolerance of combination chemotherapy with methotrexate and cytosine arabinoside
in newly diagnosed adult with Langerhans cell histiocytosis.